597 related articles for article (PubMed ID: 33191778)
1. Beneficial effects resulting from oral administration of
Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
[TBL] [Abstract][Full Text] [Related]
2. Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model.
Souza ÉL; Elian SD; Paula LM; Garcia CC; Vieira AT; Teixeira MM; Arantes RM; Nicoli JR; Martins FS
J Med Microbiol; 2016 Mar; 65(3):201-210. PubMed ID: 26758971
[TBL] [Abstract][Full Text] [Related]
3. The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice.
Garrido-Mesa N; Utrilla P; Comalada M; Zorrilla P; Garrido-Mesa J; Zarzuelo A; Rodríguez-Cabezas ME; Gálvez J
Biochem Pharmacol; 2011 Dec; 82(12):1891-900. PubMed ID: 21930116
[TBL] [Abstract][Full Text] [Related]
4. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
Ukena SN; Singh A; Dringenberg U; Engelhardt R; Seidler U; Hansen W; Bleich A; Bruder D; Franzke A; Rogler G; Suerbaum S; Buer J; Gunzer F; Westendorf AM
PLoS One; 2007 Dec; 2(12):e1308. PubMed ID: 18074031
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.
Schultz M; Strauch UG; Linde HJ; Watzl S; Obermeier F; Göttl C; Dunger N; Grunwald N; Schölmerich J; Rath HC
Clin Diagn Lab Immunol; 2004 Mar; 11(2):372-8. PubMed ID: 15013990
[TBL] [Abstract][Full Text] [Related]
6. Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.
Tian Z; Liu J; Liao M; Li W; Zou J; Han X; Kuang M; Shen W; Li H
Dig Dis Sci; 2016 Aug; 61(8):2262-2271. PubMed ID: 26846120
[TBL] [Abstract][Full Text] [Related]
7. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
[TBL] [Abstract][Full Text] [Related]
8. Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis.
Wu J; Wei Z; Cheng P; Qian C; Xu F; Yang Y; Wang A; Chen W; Sun Z; Lu Y
Theranostics; 2020; 10(23):10665-10679. PubMed ID: 32929373
[No Abstract] [Full Text] [Related]
9. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
[TBL] [Abstract][Full Text] [Related]
10. Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice.
Dong F; Xiao F; Li X; Li Y; Wang X; Yu G; Zhang T; Wang Y
J Transl Med; 2022 Jan; 20(1):33. PubMed ID: 35033121
[TBL] [Abstract][Full Text] [Related]
11. Iron Supplements Modulate Colon Microbiota Composition and Potentiate the Protective Effects of Probiotics in Dextran Sodium Sulfate-induced Colitis.
Constante M; Fragoso G; Lupien-Meilleur J; Calvé A; Santos MM
Inflamm Bowel Dis; 2017 May; 23(5):753-766. PubMed ID: 28368910
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice.
Tang H; Zhou T; Jin W; Zong S; Mamtimin T; Salama ES; Jeon BH; Liu P; Han H; Li X
Life Sci; 2023 Jul; 324():121709. PubMed ID: 37100380
[TBL] [Abstract][Full Text] [Related]
13. Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice.
Liang M; Zhang J; Yang Y; Xia Y; Liu L; Liu L; Wang Q; Gao X
World J Microbiol Biotechnol; 2022 Nov; 39(1):8. PubMed ID: 36350434
[TBL] [Abstract][Full Text] [Related]
14. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota.
Wang C; Li W; Wang H; Ma Y; Zhao X; Zhang X; Yang H; Qian J; Li J
BMC Microbiol; 2019 Nov; 19(1):246. PubMed ID: 31694526
[TBL] [Abstract][Full Text] [Related]
15. Semi-Rational Screening of Probiotics from the Fecal Flora of Healthy Adults against DSS-Induced Colitis Mice by Enhancing Anti-Inflammatory Activity and Modulating the Gut Microbiota.
Wang W; Xing W; Wei S; Gao Q; Wei X; Shi L; Kong Y; Su Z
J Microbiol Biotechnol; 2019 Sep; 29(9):1478-1487. PubMed ID: 30270604
[TBL] [Abstract][Full Text] [Related]
16. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
[TBL] [Abstract][Full Text] [Related]
17. The Administration of
Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; Fernández-Caballero JA; García F; Rodríguez-Cabezas ME; Gálvez J
Front Pharmacol; 2018; 9():468. PubMed ID: 29867475
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of RDP58 ameliorated DSS-induced colitis in intestinal microbiota dependent manner.
Zheng D; Ke X; Cai H; Yan C; Chen Y; Sun J; Chen G
Int Immunopharmacol; 2024 Jul; 136():112325. PubMed ID: 38820960
[TBL] [Abstract][Full Text] [Related]
19. Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function.
Hu J; Huang H; Che Y; Ding C; Zhang L; Wang Y; Hao H; Shen H; Cao L
J Ethnopharmacol; 2021 Feb; 266():113394. PubMed ID: 32941971
[TBL] [Abstract][Full Text] [Related]
20. Mucosal healing progression after acute colitis in mice.
Vidal-Lletjós S; Andriamihaja M; Blais A; Grauso M; Lepage P; Davila AM; Gaudichon C; Leclerc M; Blachier F; Lan A
World J Gastroenterol; 2019 Jul; 25(27):3572-3589. PubMed ID: 31367158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
